Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis

INTRODUCTION: Nonalcoholic steatohepatitis (NASH) is largely driven by the dysregulation of liver metabolism and inflammation. Bile acids and their receptor Farnesoid X receptor (FXR) play a critical role in the disease development. Here, we investigated whether INT-767, the newly-identified dual FX...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ying-Bin, Liu, Xin-Yu, Zhan, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052932/
https://www.ncbi.nlm.nih.gov/pubmed/30038487
http://dx.doi.org/10.2147/DDDT.S170518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052932/
https://www.ncbi.nlm.nih.gov/pubmed/30038487
http://dx.doi.org/10.2147/DDDT.S170518

Ejemplares similares